FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely nephrology, may be used for early diagnosis of reflux nephropathy A (RN A) in the patients with vesicoureteral reflux (VUR). For this purpose, a daily urinary volume is examined for interleukines-1, 6, transforming growth factor β. If IL-1 is 19.23±0.32 pg/ml, IL-6 is 10.04±0.08 pg/ml, transforming growth factor-β is 8.57+0.34 pg/ml, developing reflux nephropathy A is diagnosed in the children with vesicoureteral reflux.
EFFECT: technique provides the instant diagnosis of developing reflux nephropathy, enables estimating the clinical effectiveness in vesicoureteral reflux, and timeliness of its correction.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING REFLUX NEPHROPATHY | 2003 |
|
RU2239838C1 |
| METHOD FOR DIAGNOSING NEPHROSCLEROSIS IN CHILDREN SUFFERING FROM CHRONIC GLOMERULONEPHRITIS | 2005 |
|
RU2302633C1 |
| METHOD FOR DIAGNOSTICS OF RENAL PARENCHYMA DAMAGE IN CHILDREN WITH VESICOURETERIC REFLUX | 2011 |
|
RU2442982C1 |
| METHOD FOR DIAGNOSING PRECLINICAL SECONDARY NEPHROPATHIES IN CHILDREN | 2020 |
|
RU2753588C1 |
| METHOD OF RESTORATIVE TREATMENT OF CHILDREN WITH SECONDARY CHRONIC PYELONEPHRITIS | 2018 |
|
RU2707027C1 |
| METHOD OF DIAGNOSTICS OF KIDNEY DAMAGE IN CHILDREN WITH VESICOURETERAL REFLUX | 2023 |
|
RU2814399C1 |
| METHOD FOR DETERMINATION OF DEGREE OF RENAL PARENCHYMA DAMAGE IN CHILDREN WITH VESICOURETERIC REFLUX | 2011 |
|
RU2442990C1 |
| METHOD FOR DIAGNOSING EARLY CHRONIC RENAL DISEASE IN CHILDREN | 2020 |
|
RU2753581C1 |
| METHOD FOR PREDICTION OF NEPHROSCLEROSIS IN CHILDREN WITH CHRONIC PYELONEPHRITIS | 2018 |
|
RU2689790C1 |
| METHOD OF CHILDREN VESICOURETERAL REFLUX TREATMENT | 2006 |
|
RU2330601C2 |
